ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/09 | 2,395 | 2,433 | 2,367 | 2,394 | -6 | -0.3% | 614,800 |
| 2024/05/08 | 2,414 | 2,503 | 2,352 | 2,400 | -14 | -0.6% | 1,288,800 |
| 2024/05/07 | 2,471 | 2,471 | 2,286 | 2,414 | -27 | -1.1% | 1,718,000 |
| 2024/05/02 | 2,406 | 2,530 | 2,401 | 2,441 | +9 | +0.4% | 938,100 |
| 2024/05/01 | 2,451 | 2,464 | 2,394 | 2,432 | -59 | -2.4% | 905,100 |
| 2024/04/30 | 2,556 | 2,577 | 2,490 | 2,491 | -19 | -0.8% | 765,500 |
| 2024/04/26 | 2,484 | 2,514 | 2,437 | 2,510 | +69 | +2.8% | 625,800 |
| 2024/04/25 | 2,461 | 2,468 | 2,422 | 2,441 | -49 | -2% | 504,500 |
| 2024/04/24 | 2,520 | 2,542 | 2,490 | 2,490 | +6 | +0.2% | 410,400 |
| 2024/04/23 | 2,500 | 2,547 | 2,475 | 2,484 | -1 | ±0% | 605,500 |
| 2024/04/22 | 2,458 | 2,500 | 2,414 | 2,485 | +39 | +1.6% | 692,500 |
| 2024/04/19 | 2,566 | 2,572 | 2,348 | 2,446 | -138 | -5.3% | 1,997,300 |
| 2024/04/18 | 2,508 | 2,613 | 2,496 | 2,584 | +50 | +2% | 618,400 |
| 2024/04/17 | 2,613 | 2,620 | 2,497 | 2,534 | -42 | -1.6% | 915,300 |
| 2024/04/16 | 2,600 | 2,634 | 2,566 | 2,576 | -74 | -2.8% | 1,092,900 |
| 2024/04/15 | 2,672 | 2,695 | 2,636 | 2,650 | -83 | -3% | 599,500 |
| 2024/04/12 | 2,774 | 2,830 | 2,718 | 2,733 | +14 | +0.5% | 568,600 |
| 2024/04/11 | 2,820 | 2,826 | 2,696 | 2,719 | -156 | -5.4% | 1,310,100 |
| 2024/04/10 | 2,874 | 2,917 | 2,865 | 2,875 | -12 | -0.4% | 395,900 |
| 2024/04/09 | 2,850 | 2,905 | 2,843 | 2,887 | +28 | +1% | 411,900 |
| 2024/04/08 | 2,919 | 2,919 | 2,837 | 2,859 | -19 | -0.7% | 533,000 |
| 2024/04/05 | 2,928 | 2,934 | 2,862 | 2,878 | -74 | -2.5% | 556,600 |
| 2024/04/04 | 2,890 | 2,984 | 2,861 | 2,952 | +75 | +2.6% | 812,600 |
| 2024/04/03 | 2,834 | 2,919 | 2,813 | 2,877 | +7 | +0.2% | 852,700 |
| 2024/04/02 | 3,005 | 3,015 | 2,870 | 2,870 | -195 | -6.4% | 1,307,300 |
| 2024/04/01 | 3,170 | 3,175 | 3,040 | 3,065 | -45 | -1.4% | 577,900 |
| 2024/03/29 | 3,030 | 3,110 | 2,998 | 3,110 | +105 | +3.5% | 479,100 |
| 2024/03/28 | 3,020 | 3,075 | 3,005 | 3,005 | +20 | +0.7% | 381,800 |
| 2024/03/27 | 3,005 | 3,050 | 2,983 | 2,985 | -6 | -0.2% | 344,900 |
| 2024/03/26 | 3,005 | 3,025 | 2,948 | 2,991 | -44 | -1.4% | 629,100 |
| 2024/03/25 | 3,030 | 3,130 | 3,025 | 3,035 | -20 | -0.7% | 419,500 |
| 2024/03/22 | 3,085 | 3,090 | 3,025 | 3,055 | -40 | -1.3% | 429,400 |
| 2024/03/21 | 3,165 | 3,220 | 3,085 | 3,095 | -35 | -1.1% | 707,200 |
| 2024/03/19 | 3,100 | 3,255 | 3,090 | 3,130 | +131 | +4.4% | 1,359,600 |
| 2024/03/18 | 2,976 | 3,055 | 2,931 | 2,999 | +72 | +2.5% | 765,600 |
| 2024/03/15 | 2,928 | 2,976 | 2,878 | 2,927 | -68 | -2.3% | 1,062,800 |
| 2024/03/14 | 3,050 | 3,075 | 2,986 | 2,995 | -25 | -0.8% | 645,300 |
| 2024/03/13 | 3,100 | 3,100 | 2,988 | 3,020 | -25 | -0.8% | 611,300 |
| 2024/03/12 | 3,025 | 3,095 | 3,005 | 3,045 | -5 | -0.2% | 560,600 |
| 2024/03/11 | 3,065 | 3,090 | 2,932 | 3,050 | -120 | -3.8% | 1,286,600 |
| 2024/03/08 | 3,150 | 3,205 | 3,115 | 3,170 | -5 | -0.2% | 628,000 |
| 2024/03/07 | 3,190 | 3,270 | 3,165 | 3,175 | -25 | -0.8% | 790,200 |
| 2024/03/06 | 3,200 | 3,290 | 3,170 | 3,200 | -15 | -0.5% | 752,800 |
| 2024/03/05 | 3,285 | 3,330 | 3,160 | 3,215 | -85 | -2.6% | 951,600 |
| 2024/03/04 | 3,335 | 3,405 | 3,290 | 3,300 | +15 | +0.5% | 943,900 |
| 2024/03/01 | 3,495 | 3,530 | 3,265 | 3,285 | -330 | -9.1% | 2,130,000 |
| 2024/02/29 | 3,775 | 3,775 | 3,585 | 3,615 | -155 | -4.1% | 1,091,100 |
| 2024/02/28 | 3,775 | 3,815 | 3,730 | 3,770 | -35 | -0.9% | 992,700 |
| 2024/02/27 | 3,675 | 3,815 | 3,620 | 3,805 | +155 | +4.2% | 1,355,900 |
| 2024/02/26 | 3,680 | 3,735 | 3,605 | 3,650 | +165 | +4.7% | 1,416,500 |
1～
50
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 239,400円 | +52.1% | +23.3% | 0.00% | 16.92倍 | 3.53倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| ネクセラファーマ | 155,100円 | +150.7% | - | 0.00% | 39.64倍 | 2.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 321,500円 | -1.2% | -37.3% | 2.49% | 25.90倍 | 0.90倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 182,200円 | +2.6% | +11.5% | 2.85% | 21.36倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 鳥居薬 | 403,500円 | +7.3% | +16.8% | 2.97% | 24.13倍 | 0.94倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
市場注目の銘柄
チャート関連のコラム
